Christophe Libert
Profile
Christophe Libert worked as a Director of Investor Relations at Stallergenes SA.
Former positions of Christophe Libert
| Companies | Position | End |
|---|---|---|
| STALLERGENES | Public Communications Contact | 2010-07-25 |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
- Stock Market
- Insiders
- Christophe Libert
